Close

Antibody-Drug Conjugate (ADC) Discovery Service by Yeast Display

Services Workflow Features Related Services Introduction

ADC Discovery by Yeast Display Platform

Creative Biolabs stands as a trusted partner for ADC discovery through its specialized knowledge base and state-of-the-art technology combined with a dedication to client needs. We use advanced yeast display technology to advance both antibody discovery and optimization processes while making ADC development more efficient.

Fig 1. A picture demonstrating ADC. (Creative Biolabs Authorized)

This antibody selection process allows for the identification of candidates with prime affinity, specificity, and stability which are crucial for developing advanced targeted therapies. Our approach to minimizing antibody self-association helps us produce top-quality candidates required to achieve successful ADC development.

Request a Quote for Our Custom Services

Streamlined Process for Your ADC Development

Step Description
Required Starting Materials - Purified target antigen (protein, peptide, cell or other complex antigens).
- Detailed target information if available (sequence, structure, biological context).
- Existing antibody leads or research data if available.
1. Consultation & Project Design - Collaborate to define targets, scope, and deliverables.
2. Target Antigen Preparation - Define and prepare target antigen for optimal antibody selection.
3. Custom Antibody Library Generation - Create a high-diversity, tailored antibody library for your target.
4. Yeast Display Screening & Selection - Display antibody library on yeast cells and sort high-affinity candidates.
5. Characterization & Validation - Assess affinity (KD), specificity, epitope mapping, and cross-reactivity.
6. Affinity Maturation & Optimization - Optimization of stability and affinity, ensuring superior performance in ADC applications.
7. ADC Construct Design & Evaluation - Design and evaluate ADC constructs, optimizing drug conjugation and stability.
8. Final Deliverables - Prepare detailed reports with antibody sequences, affinity data, specificity profiles.

Why Choose Our Yeast Display ADC Discovery Service?

Accelerated Discovery Timeline
  • Advanced high-throughput screening platform.
  • Significantly reduces the time needed to identify top-performing ADC and single-domain antibody (sdAb) candidates.
  • Speeds up your overall discovery process, ensuring timely progress.
Enhanced Antibody Affinity and Specificity
  • Rigorous, iterative selection and optimization process.
  • Identifies antibodies with superior binding characteristics.
  • Ensures high affinity and specificity for your target, increasing the success of your ADC.
Comprehensive Service Offering
  • Full range of services from antibody library generation to final ADC construct design and sdAb isolation.
  • Supports every phase of your discovery and development process.
  • Seamless integration for a more streamlined approach.
Expert Scientific Team
  • A highly experienced team with deep expertise in antibody discovery, optimization, and ADC development.
  • Expert guidance at every stage of your project for seamless execution.
  • Ensures optimal outcomes for your ADC development.
Tailored Solutions
  • Customized solutions designed to meet your specific research goals.
  • Optimize antibodies and ADC constructs for maximum therapeutic efficacy.
  • Focus on the unique needs of your project for a more personalized approach.
Efficiency and Precision
  • Cutting-edge FACS-based screening technology ensures rapid and precise identification.
  • Efficiently enriches top-performing antibodies and ADCs, delivering the best candidates for your research.
Tailored Results
  • Optimized strategies isolate antibodies that meet your functional and structural specifications.
  • Reliable and actionable results tailored to your exact needs, ensuring impactful discoveries.
Data-Driven Insights
  • Detailed, comprehensive reports offering valuable data and insights.
  • Empowers you to make informed decisions in further research, development, and optimization of your ADC candidates.

Related Services

We provide a comprehensive suite of yeast display-based antibody discovery services to advance your research and therapeutic projects, including but not limited to:

Background

Antibody-Drug Conjugates (ADCs) provide targeted cancer treatment by fusing monoclonal antibodies with cytotoxic drugs which minimizes harm to healthy cells. Functional ADC development requires discovering antibodies with both high-affinity binding to tumors and specific targeting capabilities.

The Yeast Display ADC Discovery Service streamlines antibody identification through yeast display technology which allows for high-throughput screening of extensive antibody collections. Yeast display technology allows for eukaryotic post-translational modifications that yield functional and stable antibodies unlike older methods. Antibody fragment presentation on yeast cells enables swift identification of optimal candidates which speeds up ADC development and enhances therapeutic results.

Partner with Creative Biolabs to Advance Your ADC Research

Creative Biolabs gives you precisely targeted innovative solutions made to accelerate your ADC research process. Contact our team today to discuss your project details and explore our ways to help you meet your development goals.


All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

Online Inquiry
CONTACT US
USA:
Europe:
Germany:
Call us at:
USA:
UK:
Germany:
Fax:
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2026 Creative Biolabs. | Contact Us